Latest PEG ratio for NKGen Biotech- Warrants (01/09/2028): 0.03 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow0.03
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
NKGen Biotech- Warrants (01/09/2028) posts a PEG ratio of 0.03. That is above the sector sector average of -3.72. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a PEG ratio near -3.72 is typical. NKGen Biotech- Warrants (01/09/2028)'s 0.03 is higher that level. That is roughly 100.7% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
NKGen Biotech- Warrants (01/09/2028)'s PEG ratio of 0.03 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.
Context for NKGNW's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -3.72), and (3) consistency with growth and profitability. This page covers the first two; NKGen Biotech- Warrants (01/09/2028)'s other metric pages and overview cover the third.